Content
- Classes of Pharmaceuticals (biopharmaceuticals and small-molecule drugs)
- Case studies: Clinical development of selected drugs
- Clinical drug development process
- Selected aspects of drug discovery and preclinical development
- Overview clinical study designs, outcomes and inclusion/exclusion criteria
- Randomized Controlled Trials (RCTs): Randomization, Blinding and Placebos
- Epidemiological study designs
- Conduct of clinical trials, data analysis and interpretation
- Ethical aspects, the origins and principles of Good Clinical Practice (GCP)
- Regulatory bodies, international regulations (EMEA, FDA, ICH)
- Phase IV/Post-marketing surveillance, life cycle management
- Interfaces: Regulatory Affairs and Pharmacovigilance, Marketing and Product Life Cycle Management
- Special chapters: Advanced Therapy Medicinal Products (ATMPs), repurposing, special populations
Teaching method
- Lecture with structured exercises
- Dialogue and discussion
- Group work
- Blended learning
- Guest lectures
Examination
Endprüfung
Exercises during class, exam
Teaching language
Englisch